Novartis AG
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Share of New Product Launches with Global Access by Year
Share of New Product Launches with Global Access Strategy (%) (%)
Novartis Share of New Product Launches with Global Access: 100.0% in FY2025, unchanged from a year earlier.
Where the FY2025 figure comes from
“| New medicines launched with a global access strategy (%) | 100 | 100 | 33 | ”
Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
Reported in ESG Data Summary 2025.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Share of New Product Launches with Global Access Strategy (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 100.0% | 0.0 pts | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2024 | Dec 31, 2024 | 100.0% | 0.0 pts | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2023 | Dec 31, 2023 | 100.0% | 0.0 pts | Novartis Form 6-K (0001370368-24-000008) ↗ |
| FY2022 | Dec 31, 2022 | 100.0% | 0.0 pts | Novartis Form 6-K (0001370368-24-000008) ↗ |
| FY2021 | Dec 31, 2021 | 100.0% | – | Novartis Form 6-K (0001370368-24-000008) ↗ |
Cite this data
StockData. (2026). Novartis Share of New Product Launches with Global Access (%), annual FY2021–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/access-global-strategy-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.